{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:24:19Z","timestamp":1768832659022,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017160","name":"Beni Suef University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017160","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In a precarious world of rapidly growing pandemics, the field of vaccine production has witnessed considerable growth. Bacillus Calmette-Gu\u00e9rin (BCG) is a live-attenuated vaccine and a part of the immunization program in 157 countries. The quality control is based on a potency test through viable cell enumeration. The colony-forming unit (CFU) assay is the official method, however, it often yields fluctuating results, suffers from medium cracking, and requires lengthy analysis (~\u200928\u00a0days). Flow cytometric analysis was proposed earlier, but it was coupled with a Coulter counter for measuring the entire bacterial population (live\/dead). In the present study, thiazole orange\/propidium iodide dyes supplemented with fluorogenic reference beads were employed for viable counting, eliminating the need for a Coulter counter. Both the flow cytometry and the colorimetric technique employing tetrazolium salt were validated and compared to the CFU assay. The colorimetric assay displayed high precision, accuracy, and a strong positive correlation with the CFU assay. The flow cytometry assay demonstrated high precision and a notable ability to distinguish different forms of BCG cells (live, injured, and dead). It also exhibited a perfect positive correlation with the CFU assay. Both methods reduced the analysis time by\u2009&gt;\u200926\u00a0days and eliminated the need for human intervention by automating the test.<\/jats:p>","DOI":"10.1038\/s41598-023-38657-x","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T17:02:02Z","timestamp":1689699722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development of a fast and precise potency test for BCG vaccine viability using flow cytometry compared to MTT and colony-forming unit assays"],"prefix":"10.1038","volume":"13","author":[{"given":"Hend M.","family":"Moghawry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed E.","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareeman","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh","family":"AbdelGhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Dishisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"key":"38657_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/1469-0691.12555","volume":"20","author":"E Cambau","year":"2014","unstructured":"Cambau, E. & Drancourt, M. Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882. Clin. Microbiol. Infect. 20, 196\u2013201 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"38657_CR2","doi-asserted-by":"publisher","DOI":"10.1055\/b-005-148876","volume-title":"Medical Microbiology","author":"FH Kayser","year":"2005","unstructured":"Kayser, F. H., Bienz, K. A., Eckert, J. & Zinkernagel, R. M. Medical Microbiology (Thieme, 2005). https:\/\/doi.org\/10.1055\/b-005-148876."},{"key":"38657_CR3","first-page":"53","volume":"8","author":"S Luca","year":"2013","unstructured":"Luca, S. & Mihaescu, T. History of BCG vaccine. Maedica (Buchar) 8, 53\u201358 (2013).","journal-title":"Maedica (Buchar)"},{"key":"38657_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-45024-6","volume-title":"Vaccine Analysis: Strategies, Principles, and Control","author":"BK Nunnally","year":"2015","unstructured":"Nunnally, B. K., Turula, V. E. & Sitrin, R. D. Vaccine Analysis: Strategies, Principles, and Control (Springer Berlin Heidelberg, 2015). https:\/\/doi.org\/10.1007\/978-3-662-45024-6."},{"key":"38657_CR5","unstructured":"World Health Organization. Tuberculosis profile: Global. https:\/\/worldhealthorg.shinyapps.io\/tb_profiles\/?_inputs_&lan=%22EN%22&entity_type=%22group%22&group_code=%22global%22 (Accessed 15 December 2022) (2020)."},{"key":"38657_CR6","unstructured":"Omar, S. V. Innovative approaches to tuberculosis diagnosis with emphasis on nucleic acid amplification tests in a resource constrained high burden tuberculosis setting. PhD Dissertation, University of Pretoria (2015)."},{"key":"38657_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/13102818.2014.927200","volume":"28","author":"T Stefanova","year":"2014","unstructured":"Stefanova, T. Quality control and safety assessment of BCG vaccines in the post-genomic era. Biotechnol. Biotechnol. Equip. 28, 387\u2013391 (2014).","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"38657_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales, A., Eidinger, D. & Bruce, A. W. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J. Urol. 116, 180\u2013182 (1976).","journal-title":"J. Urol."},{"key":"38657_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","volume":"325","author":"DL Lamm","year":"1991","unstructured":"Lamm, D. L. et al. A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette-Gu\u00e9rin for transitional-cell carcinoma of the bladder. N. Engl. J. Med. 325, 1205\u20131209 (1991).","journal-title":"N. Engl. J. Med."},{"key":"38657_CR10","unstructured":"British Pharmacopoeia: BCG vaccine (2017)."},{"key":"38657_CR11","first-page":"93","volume":"68","author":"JB Milstien","year":"1990","unstructured":"Milstien, J. B. & Gibson, J. J. Quality control of BCG vaccine by WHO: A review of factors that may influence vaccine effectiveness and safety. Bull. World Health Organ. 68, 93\u2013108 (1990).","journal-title":"Bull. World Health Organ."},{"key":"38657_CR12","first-page":"1","volume":"28","author":"W-C Lian","year":"2012","unstructured":"Lian, W.-C., Hsieh, W.-C., Yang, H.-C. & Lo, Y.-W. Seed history and in-process control for freeze-dried BCG vaccine produced in Taiwan. Epidemiol. Bull. 28, 1\u201310 (2012).","journal-title":"Epidemiol. Bull."},{"key":"38657_CR13","unstructured":"World Health Organization. WHO Technical Report Series No. 979, Annex 3 - Recommendations to assure the quality, safety and efficacy of BCG vaccines. (2013)."},{"key":"38657_CR14","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.5504\/BBEQ.2011.0048","volume":"25","author":"Y-C Yang","year":"2011","unstructured":"Yang, Y.-C., Tsai, M.-H. & Cheng, H.-F. Determine the potency of BCG vaccines by flow cytometer. Biotechnol. Biotechnol. Equip. 25, 2394\u20132398 (2011).","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"38657_CR15","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/S0264-410X(99)00023-7","volume":"17","author":"SK Kairo","year":"1999","unstructured":"Kairo, S. K., Bedwell, J., Tyler, P. C., Carter, A. & Corbel, M. J. Development of a tetrazolium salt assay for rapid determination of viability of BCG vaccines. Vaccine 17, 2423\u20132428 (1999).","journal-title":"Vaccine"},{"key":"38657_CR16","volume-title":"Assay Guidance Manual","author":"TL Riss","year":"2004","unstructured":"Riss, T. L. et al. Cell viability assays. In Assay Guidance Manual (eds Markossian, S. et al.) (Eli Lilly & Company and the National Center for Advancing Translational Sciences, 2004)."},{"key":"38657_CR17","doi-asserted-by":"publisher","first-page":"e0219713","DOI":"10.1371\/journal.pone.0219713","volume":"14","author":"L Benov","year":"2019","unstructured":"Benov, L. Effect of growth media on the MTT colorimetric assay in bacteria. PLoS One 14, e0219713 (2019).","journal-title":"PLoS One"},{"key":"38657_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.mimet.2012.05.015","volume":"90","author":"K Kolibab","year":"2012","unstructured":"Kolibab, K., Derrick, S. C., Jacobs, W. R. & Morris, S. L. Characterization of an intracellular ATP assay for evaluating the viability of live attenuated mycobacterial vaccine preparations. J. Microbiol. Methods 90, 245\u2013249 (2012).","journal-title":"J. Microbiol. Methods"},{"key":"38657_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mimet.2016.08.027","volume":"130","author":"NN Ugarova","year":"2016","unstructured":"Ugarova, N. N. et al. A simplified ATP method for the rapid control of cell viability in a freeze-dried BCG vaccine. J. Microbiol. Methods 130, 48\u201353 (2016).","journal-title":"J. Microbiol. Methods"},{"key":"38657_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.24171\/j.phrp.2017.8.6.06","volume":"8","author":"E Gweon","year":"2017","unstructured":"Gweon, E. et al. Development of a new approach to determine the potency of Bacille Calmette-Gu\u00e9rin vaccines using flow cytometry. Osong Public Heal. Res. Perspect. 8, 389\u2013396 (2017).","journal-title":"Osong Public Heal. Res. Perspect."},{"key":"38657_CR21","first-page":"1","volume":"93","author":"H Davey","year":"2020","unstructured":"Davey, H. & Guyot, S. Estimation of microbial viability using flow cytometry. Curr. Protoc. Cytom. 93, 1\u201313 (2020).","journal-title":"Curr. Protoc. Cytom."},{"key":"38657_CR22","volume-title":"Flow Cytometry in Microbiology","author":"MG Wilkinson","year":"2015","unstructured":"Wilkinson, M. G. Flow Cytometry in Microbiology (Caister Academic Press, 2015)."},{"key":"38657_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/BF00174481","volume":"38","author":"JP Diaper","year":"1992","unstructured":"Diaper, J. P., Tither, K. & Edwards, C. Rapid assessment of bacterial viability by flow cytometry. Appl. Microbiol. Biotechnol. 38, 268\u2013272 (1992).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"38657_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nmeth.2365","volume":"10","author":"N Aghaeepour","year":"2013","unstructured":"Aghaeepour, N. et al. Critical assessment of automated flow cytometry data analysis techniques. Nat. Methods 10, 228\u2013238 (2013).","journal-title":"Nat. Methods"},{"key":"38657_CR25","unstructured":"British pharmacopoeia: Flow cytometry (2017)."},{"key":"38657_CR26","first-page":"11.3.1","volume":"7","author":"HM Davey","year":"1999","unstructured":"Davey, H. M., Weichart, D. H., Kell, D. B. & Kaprelyants, A. S. Estimation of microbial viability using flow cytometry. Curr. Protoc. Cytom. 7, 11.3.1-11.3.20 (1999).","journal-title":"Curr. Protoc. Cytom."},{"key":"38657_CR27","unstructured":"Enzo Life Sciences. %CV in ELISA how to reduce them and why they are important. https:\/\/www.enzolifesciences.com\/science-center\/technotes\/2018\/january\/cv-in-elisa-how-to-reduce-them-and-why-they-re-important\/ (Accessed 15 December 2022)."},{"key":"38657_CR28","unstructured":"ICH. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH Harmoised Tripartite Guideline Validation of Analytical Procedures. In Text and Methodology Q2(R1): Step 4 (2005)."},{"key":"38657_CR29","unstructured":"Chaloner-Larsson, G., Anderson, R. & Egan, A. In A WHO guide to good manufacturing practice (GMP) requirements Part 2\u202f: Validation, Global Programme for Vaccines and Immunization, Vaccine Supply and Quality (1997)."},{"key":"38657_CR30","unstructured":"ISO\/IEC 17025. clause 5- structural requirements (2017)."},{"key":"38657_CR31","unstructured":"BD Bioscience. BD Cell Viability Kit (2015)."},{"key":"38657_CR32","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1002\/cpcy.53","volume":"87","author":"N Selliah","year":"2019","unstructured":"Selliah, N. et al. Flow cytometry method validation protocols. Curr. Protoc. Cytom. 87, e53 (2019).","journal-title":"Curr. Protoc. Cytom."},{"key":"38657_CR33","doi-asserted-by":"publisher","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","volume":"8","author":"A Zwerling","year":"2011","unstructured":"Zwerling, A. et al. The BCG world atlas: A database of global BCG vaccination policies and practices. PLoS Med. 8, e1001012 (2011).","journal-title":"PLoS Med."},{"key":"38657_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/2FB978-0-323-35761-6.00004-3","author":"RG Douglas","year":"2018","unstructured":"Douglas, R. G. & Samant, V. B. The vaccine industry. Plotkin\u2019s Vaccines https:\/\/doi.org\/10.1016\/2FB978-0-323-35761-6.00004-3 (2018).","journal-title":"Plotkin\u2019s Vaccines"},{"key":"38657_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/INF.0b013e3182458289","volume":"31","author":"S Biering-S\u00f8rensen","year":"2012","unstructured":"Biering-S\u00f8rensen, S. et al. Small randomized trial among low\u2013birth-weight children receiving Bacillus Calmette-Gu\u00e9rin vaccination at first health center contact. Pediatr. Infect. Dis. J. 31, 306\u2013308 (2012).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"38657_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006885.PUB2","author":"PF Shang","year":"2011","unstructured":"Shang, P. F. et al. Intravesical Bacillus Calmette-Gu\u00e9rin versus epirubicin for Ta and T1 bladder cancer. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD006885.PUB2 (2011).","journal-title":"Cochrane Database Syst. Rev."},{"key":"38657_CR37","doi-asserted-by":"publisher","first-page":"e01637","DOI":"10.1128\/spectrum.01637-21","volume":"9","author":"L Benov","year":"2021","unstructured":"Benov, L. Improved formazan dissolution for bacterial MTT assay. Microbiol. Spectr. 9, e01637-e1721 (2021).","journal-title":"Microbiol. Spectr."},{"key":"38657_CR38","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3324\/haematol.2009.018911","volume":"95","author":"E Domingo","year":"2010","unstructured":"Domingo, E. et al. Enhanced sensitivity of flow cytometry for routine assessment of minimal residual disease. Haematologica 95, 691\u2013692 (2010).","journal-title":"Haematologica"},{"key":"38657_CR39","unstructured":"Alsharif, R. & Godfrey, W. Bacterial detection and live\/dead discrimination by flow cytometry. Microbial Cytometry Application Note. BD Biosciences, Immunocytometry Systems (2002)."},{"key":"38657_CR40","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/jam.13508","volume":"123","author":"F Ou","year":"2017","unstructured":"Ou, F., McGoverin, C., Swift, S. & Vanholsbeeck, F. Absolute bacterial cell enumeration using flow cytometry. J. Appl. Microbiol. 123, 464\u2013477 (2017).","journal-title":"J. Appl. Microbiol."},{"key":"38657_CR41","first-page":"211","volume":"77","author":"L Lugosi","year":"1992","unstructured":"Lugosi, L. Standardized viability test required for preventive, immunomodulator and recombinant BCG vaccine. Dev. Biol. Stand. 77, 211\u2013215 (1992).","journal-title":"Dev. Biol. Stand."},{"key":"38657_CR42","unstructured":"Mohammed, A. M. A. Evaluation of viability of BCG vaccine using a conventional viable count method and a tetrazolium salt rapid assay method. PhD Dissertation, Cairo Univ. (2012)."},{"key":"38657_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/13102818.2003.10819206","volume":"17","author":"TR Stefanova","year":"2003","unstructured":"Stefanova, T. R. & Zhelev, P. Z. Alternative rapid method for viability determination of BCG vaccine by tetrazolium salt assay. Biotechnol. Biotechnol. Equip. 17, 124\u2013128 (2003).","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"38657_CR44","unstructured":"EudraLex. EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use Annex 15: Qualification and Validation. 4, (2015)."},{"key":"38657_CR45","doi-asserted-by":"publisher","DOI":"10.3109\/9781420019797","volume-title":"Validation of Pharmaceutical Processes","author":"JP Agalloco","year":"2007","unstructured":"Agalloco, J. P. & Carleton, F. J. Validation of Pharmaceutical Processes (CRC Press, 2007)."},{"key":"38657_CR46","doi-asserted-by":"publisher","DOI":"10.1385\/0-89603-150-0:543","volume-title":"Animal Cell Culture. Methods in Molecular Biology","author":"G Ormerod","year":"1990","unstructured":"Ormerod, G. & Imrie, R. Flow cytometry. In Animal Cell Culture. Methods in Molecular Biology (eds Walker, J. M. et al.) (Humana Press, 1990). https:\/\/doi.org\/10.1385\/0-89603-150-0:543."},{"key":"38657_CR47","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1128\/jcm.33.5.1231-1237.1995","volume":"33","author":"MA Norden","year":"1995","unstructured":"Norden, M. A., Kurzynski, T. A., Bownds, S. E., Callister, S. M. & Schell, R. F. Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. J. Clin. Microbiol. 33, 1231\u20131237 (1995).","journal-title":"J. Clin. Microbiol."},{"key":"38657_CR48","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.vaccine.2003.05.002","volume":"22","author":"MA Chambers","year":"2004","unstructured":"Chambers, M. A. et al. A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome\u2122) protects guinea pigs from lethal tuberculosis. Vaccine 22, 1063\u20131071. https:\/\/doi.org\/10.1016\/j.vaccine.2003.05.002 (2004).","journal-title":"Vaccine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38657-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38657-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38657-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T17:03:35Z","timestamp":1689699815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38657-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38657"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38657-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]},"assertion":[{"value":"17 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11606"}}